These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current situation and perspective for treatment of acute myelogenous leukemia in adults]. Fukushima T, Ueda T. Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819 [Abstract] [Full Text] [Related]
7. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia. Fouillard L, Labopin M, Meloni G, Polge E, Gorin NC, Frassoni F. Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615 [No Abstract] [Full Text] [Related]
8. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia. Lee JH, Choi SJ, Lee JH, Park JH, Kim H, Joo YD, Lee WS, Zang DY, Kim HJ, Lee KH, Cooperative Study Group A for Hematology. Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580 [Abstract] [Full Text] [Related]
9. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement. Castagnola C, Nozza A, Corso A, Bernasconi C. Haematologica; 1997 Jun; 82(5):577-80. PubMed ID: 9407724 [Abstract] [Full Text] [Related]
10. Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs. Eisele L, Günther F, Ebeling P, Nabring J, Dührsen U, Dürig J. Onkologie; 2010 Jun; 33(12):658-64. PubMed ID: 21124036 [Abstract] [Full Text] [Related]
12. Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia. Ohno R, Yokomaku S, Okumara M, Tanimoto M, Morishita Y, Morishima Y, Kodera Y, Saito H. Haematol Blood Transfus; 1990 Aug; 33():304-8. PubMed ID: 2182424 [No Abstract] [Full Text] [Related]
13. Relapse and death during first remission in acute myeloid leukemia. Yanada M, Garcia-Manero G, Borthakur G, Ravandi F, Kantarjian H, Estey E. Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012 [No Abstract] [Full Text] [Related]
14. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G. Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879 [Abstract] [Full Text] [Related]
15. Comparison of intensive consolidation therapy and autologous bone marrow transplantation in acute myeloid leukaemia. The Leiden experience. Willemze R, Fibbe WE, Richel DJ, Kluin-Nelemans JC, Zwaan FE. Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():73. PubMed ID: 2697407 [No Abstract] [Full Text] [Related]
16. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy. Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S. Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917 [Abstract] [Full Text] [Related]
19. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X. Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754 [Abstract] [Full Text] [Related]
20. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD. Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]